Skip to main navigation Skip to search Skip to main content

Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors

Karen E. Sheppard, Carleen Cullinane, Katherine M. Hannan, Meaghan Wall, Joanna Chan, Frances Barber, Jung Foo, Donald Cameron, Amelia Neilsen, Pui Ng, Jason Ellul, Margarete Kleinschmidt, Kathryn M. Kinross, David D. Bowtell, James G. Christensen, Rodney J. Hicks, Ricky W. Johnstone, Grant A. McArthur, Ross D. Hannan, Wayne A. PhillipsRichard B. Pearson*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

73 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science